Medicine
Rivastigmine 4.5 mg capsule
Rivastigmine 4.5 mg capsule is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C…
Key facts
- Active ingredient (INN)
- Rivastigmine
- Brand
- Sold under the generic name
- Strength
- 4.5 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 blister pack, 30 capsules, 60 capsules and 26 more
- Manufacturers
- Alembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaMacleods PharmaceuticalsIndiaAurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaCadila PharmaceuticalsIndiaModavar PharmaceuticalsChartwell RX
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06DA03 Rivastigmine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2010
- Identifiers
- RxCUI 312835, 312836, 314214 +1DailyMed set ID bac9ca81-db70-41aa-82af-6c5bb8496846, e7e641fe-39bd-4681-a430-6dedeb6d6af5, 0e20124c-725a-0145-996c-2ff908703162 +6NDC 62756-147, 71209-014, 55111-354 +6Application ANDA077131, ANDA203844, ANDA077130 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 box, unit-dose / 10 capsule in 1 blister pack | 46708-065-10 | Alembic PharmaceuticalsIndia | 13 June 2012 |
| 30 capsule in 1 bottle | 46708-065-30 | Alembic PharmaceuticalsIndia | 13 June 2012 |
| 60 capsule in 1 bottle | 46708-065-60 | Alembic PharmaceuticalsIndia | 13 June 2012 |
| 500 capsule in 1 bottle | 46708-065-71 | Alembic PharmaceuticalsIndia | 13 June 2012 |
| 1000 capsule in 1 bottle | 46708-065-91 | Alembic PharmaceuticalsIndia | 13 June 2012 |
| 100 blister pack in 1 box, unit-dose / 10 capsule in 1 blister pack | 62332-065-10 | Alembic PharmaceuticalsIndia | 12 June 2022 |
| 30 capsule in 1 bottle | 62332-065-30 | Alembic PharmaceuticalsIndia | 12 June 2022 |
| 60 capsule in 1 bottle | 62332-065-60 | Alembic PharmaceuticalsIndia | 12 June 2022 |
| 500 capsule in 1 bottle | 62332-065-71 | Alembic PharmaceuticalsIndia | 12 June 2022 |
| 1000 capsule in 1 bottle | 62332-065-91 | Alembic PharmaceuticalsIndia | 12 June 2022 |
| 500 capsule in 1 bottle | 65862-650-05 | Aurobindo PharmaIndia | 25 March 2016 |
| 60 capsule in 1 bottle | 65862-650-60 | Aurobindo PharmaIndia | 25 March 2016 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 65862-650-78 | Aurobindo PharmaIndia | 25 March 2016 |
| 60 capsule in 1 bottle | 71209-014-03 | Cadila PharmaceuticalsIndia | 11 February 2014 |
| 500 capsule in 1 bottle | 71209-014-10 | Cadila PharmaceuticalsIndia | 11 February 2014 |
| 100 capsule in 1 bottle | 55111-354-01 | Dr. Reddy's LaboratoriesIndia | 1 September 2011 |
| 500 capsule in 1 bottle | 55111-354-05 | Dr. Reddy's LaboratoriesIndia | 1 September 2011 |
| 30 capsule in 1 bottle | 55111-354-30 | Dr. Reddy's LaboratoriesIndia | 1 September 2011 |
| 60 capsule in 1 bottle | 55111-354-60 | Dr. Reddy's LaboratoriesIndia | 1 September 2011 |
| 3 blister pack in 1 box, unit-dose / 10 capsule in 1 blister pack | 33342-091-06 | Macleods PharmaceuticalsIndia | 2 September 2014 |
| 60 capsule in 1 bottle | 33342-091-09 | Macleods PharmaceuticalsIndia | 2 September 2014 |
| 10 blister pack in 1 box, unit-dose / 10 capsule in 1 blister pack | 33342-091-12 | Macleods PharmaceuticalsIndia | 2 September 2014 |
| 500 capsule in 1 bottle | 33342-091-15 | Macleods PharmaceuticalsIndia | 2 September 2014 |
| 500 capsule in 1 bottle | 62756-147-13 | Sun Pharmaceutical IndustriesIndia | 1 July 2010 |
| 100 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack | 62756-147-61 | Sun Pharmaceutical IndustriesIndia | 1 July 2010 |
| 60 capsule in 1 bottle | 62756-147-86 | Sun Pharmaceutical IndustriesIndia | 1 July 2010 |
| 60 capsule in 1 bottle | 62135-902-60 | Chartwell RX | 4 January 2023 |
| 60 capsule in 1 bottle | 72241-013-03 | Modavar Pharmaceuticals | 5 October 2021 |
| 500 capsule in 1 bottle | 72241-013-10 | Modavar Pharmaceuticals | 5 October 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Rivastigmine
Clinical summary
Rivastigmine is a cholinesterase inhibitor indicated for treatment of mild, moderate, and severe dementia of the Alzheimer’s type (AD), among other approved uses. It is available as capsules and transdermal patches for oral use. MedsAcross supplies Rivastigmine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RivastigmineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Exelon prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Exelon: European public assessment report (EPAR) · European Medicines Agency
- Prometax: European public assessment report (EPAR) · European Medicines Agency
Need Rivastigmine 4.5 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.